Fundraising Fox

Cellular Longevity

San Francisco, US · Founded 2019 · Delaware corporation · 3 known investors

Biotech

Founders & leadership

Cellular Longevity was founded in 2019 by Celine-Lea Halioua-Haubold.

CH
Celine-Lea Halioua-HauboldFounder

Board

LD
Laura DemingBoard director
KZ
Kevin ZhangBoard director
LR
Linda RhodesBoard director
BS
Blake SchollBoard director

Investors · 3

Collaborative FundreportedNew York · $500K – $1M
First Round CapitalreportedSan Francisco · $2M
Khosla VenturesreportedMenlo Park · $5K – $50M

Reported raises · per SEC filings

Form D private placements

$137.3M disclosed across 6 rounds · 2020–2024

▶$22.2MraisedOct 2024 · 12 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Laura DemingDirector
  • Linda RhodesDirector
  • Celine-Lea Halioua-HauboldExecutive Officer, Director
  • Kevin ZhangDirector
  • Blake SchollDirector
Offering amount
$32.5M
Amount sold
$22.2M
First sale
Oct 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$76.3MraisedMar 2024 · 38 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Blake SchollDirector
  • Kevin ZhangDirector
  • Celine-Lea Halioua-HauboldExecutive Officer, Director
  • Laura DemingDirector
Offering amount
$76.3M
Amount sold
$76.3M
First sale
Mar 2024
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$27.7MraisedOct 2021 · 42 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Celine-Lea Halioua-HauboldExecutive Officer, Director
Offering amount
$28.8M
Amount sold
$27.7M
First sale
Aug 2021
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$831.5KraisedJun 2021 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Celine-Lea Halioua-HauboldExecutive Officer, Director
Offering amount
$4M
Amount sold
$831.5K
First sale
Dec 2020
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.4MraisedJun 2021 · 28 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Celine-Lea Halioua-HauboldExecutive Officer, Director
Offering amount
$5.4M
Amount sold
$5.4M
First sale
Sep 2020
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.9MraisedJan 2020 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Celine-Lea Halioua-HauboldExecutive Officer, Director
Offering amount
$4.9M
Amount sold
$4.9M
First sale
Jan 2020
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Lowenstein Represents Startup Loyal in $27 Million Series A Funding Round Promoting Longevity for Dogs | Lowenstein Sandler LLPlowenstein.com · Jun 2023

Frequently asked questions

Who founded Cellular Longevity?
Cellular Longevity was founded by Celine-Lea Halioua-Haubold in 2019.
Who are Cellular Longevity's investors?
Cellular Longevity's investors include Collaborative Fund, First Round Capital, Khosla Ventures.
How much funding has Cellular Longevity raised?
Cellular Longevity has disclosed $137.3M raised across 6 rounds.
Where is Cellular Longevity headquartered?
Cellular Longevity is headquartered in San Francisco, US.